World Journal of Social Science
November 13, 2023
Lee Fergusson, Javier Ortiz Cabrejos, Anna Bonshek
More than 60 well-controlled empirical studies since 1974 have indicated there is a statistically observable causal link between the number of people who practice the Transcendental Meditation technique and the state of order, harmony and prosperity in a city, region, country or the world. Such a phenomenon is based on the level of brainwave coherence generated by the practice and the effect...
Middle East Current Psychiatry
November 13, 2023
Pia Maria Ghanimé, Zeinab Bazzi, Joseph Kazan et al.
Abstract Background Trends in cannabis use suggest a global increase in the past decade. Current evidence associates cannabis use with an increased risk of psychosis. This association has prompted a growing research interest in the association between cannabis use and psychiatric disorders, especially psychotic disorders. This study aims to gain a better understanding of the effect of cannabis...
Journal of Psychopharmacology
November 10, 2023
David Wolinsky, Frederick Streeter Barrett, Ryan Vandrey
16 citations
Cannabis and classic psychedelics are controlled substances with emerging evidence of efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been regarded as having psychedelic effects in contemporary literature, despite many examples of historical use along with classic psychedelics to attain altered states of consciousness. Research into the “psychedelic”...
npj Mental Health Research
November 8, 2023
Omer A. Syed, Benjamin Tsang
4 citations
The recent years have seen an unprecedented surge of psychedelic research. Studies with psilocybin (colloquially known as magic mushrooms), in particular, have shown promise in ameliorating symptoms of treatment-refractory depression, anxiety, and substance use disorder, among others 1 , 2 . Microdosing, the practice of regularly taking roughly a tenth of full psychedelic doses, is becoming...
Life
November 8, 2023
Bruno Pires, Luana M. Rosendo, Ana Teresa Brinca et al.
15 citations
This review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine. These compounds have been investigated for their potential in treating a range of psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), drug...
Journal of Neuroscience
November 8, 2023
Lindsay P. Cameron, Joseph Benetatos, Vern Lewis et al.
88 citations
Serotonergic psychedelics, such as psilocybin and LSD, have garnered significant attention in recent years for their potential therapeutic effects and unique mechanisms of action. These compounds exert their primary effects through activating serotonin 5-HT2A receptors, found predominantly in cortical regions. By interacting with these receptors, serotonergic psychedelics induce alterations in...
PsyArXiv
November 7, 2023
Mika Turkia
2 citations
preprint
Following advice received in a dream, a woman in her early thirties, suffering from depression, anxiety, and sleep disorders caused by complex trauma in her childhood, experimented with 'microdosing' or psycholytic dosing of Amanita muscaria (fly agaric) mushrooms. During a 3.5-month period with an intuition-based, gradually declining dosing scheme, her symptoms significantly decreased. No...
Pharmacological Reports
November 6, 2023
Paweł Holas, Justyna Kamińska
39 citations
Abstract There has been increasing scientific and clinical interest in studying psychedelic and meditation-based interventions in recent years, both in the context of improving mental health and as tools for understanding the mind. Several authors suggest neurophysiological and phenomenological parallels and overlaps between psychedelic and meditative states and suggest synergistic effects of...
Læknablaðið
November 3, 2023
Ragnar Olafsson, Karól Kvaran, Kristín Ketilsdóttir et al.
5 citations
INTRODUCTION: Interest in the use of psychedelics has increased following reports of their possible therapeutic potential. However, little is known about the knowledge of and attitudes towards the substances among health care professional who provide treatment for mental disorders in Iceland. An online survey was therefore conducted among members of the Icelandic associations of psychiatrists,...
Expert Review of Clinical Pharmacology
November 2, 2023
Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum et al.
30 citations
Clinicians should be regularly informed about the range of NPS and their medical, psychobiological and psychopathological risks both in the acute and long term. Future research should focus on an integrative model in which pro-drug websites' analyses are combined with advanced research approaches, including computational chemistry studies so that in vitro and in vivo preclinical studies of...